FDA Inspection
BioAccess, Inc.BioAccess, Inc. – FDA Inspection, Aug 20, 2024
Record Details
This FDA Inspection record concerns BioAccess, Inc., with an inspection on August 20, 2024, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 1163c5a4-4acc-41bc-9c82-ce0676d966ea
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1246993
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 820.100(a)Lack of or inadequate procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of BioAccess, Inc.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| April 22, 2025 | NAI | Baltimore District Office | Postmarket Assurance: Medical Devices |
| November 17, 2016 | NAI | Center for Devices and Radiological Health | Compliance: Devices |
| April 13, 2010 | VAI | Center for Devices and Radiological Health | Compliance: Devices |
Other documents for BioAccess, Inc.
- FDA Inspection 1267578 - 2025-04-22
- FDA Inspection 993631 - 2016-11-17
- FDA Inspection 656896 - 2010-04-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.